Author:
Li Juan,Lu Shun,Tian Yuke,Jiang Lan,Li Lu,Xie Shao-Hua,Li Qiang
Reference51 articles.
1. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy;Remon;Annals of Oncology : Official Journal of the European Society For Medical Oncology,2021
2. Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study;De Ruysscher;Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology,2019
3. Asian thoracic oncology research group expert consensus statement on optimal management of stage III NSCLC;Tan;J Thorac Oncol,2020
4. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Non-Small Cell Lung Cancer (Version 3.2023): © 2021 National Comprehensive Cancer Network, Inc. ; 2023. Available from: Available at https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1450.
5. OA20.01 long term survival in operable stage iiia nsclc patients treated with neoadjuvant nivolumab plus chemotherapy - nadim study;Provencio;J Thorac Oncol,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献